Cannara Biotech (LOVFF) received final approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange. In connection with the Uplisting, the Company’s common shares will commence trading on the TSX at the opening of the market on March 2, under the trading symbol “LOVE”. Concurrently, the Company’s common shares will be delisted from the TSXV effective March 2.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LOVFF:
- Cannara Biotech initiated with a Buy at TD Securities
- Cannara Biotech Schedules Investor Webcast to Highlight Cannabis Operations
- Cannara Biotech Secures C$6.3 Million Premium Private Placement from Phoenician Capital
- Cannara Biotech prices 3M shares at C$2.10 in private placement
- Cannara Biotech Secures Conditional TSX Approval in Strategic Uplisting Move